Related Experiment Video

Updated: Jan 28, 2026

Induction and Assessment of Exertional Skeletal Muscle Damage in Humans
08:33

Induction and Assessment of Exertional Skeletal Muscle Damage in Humans

Published on: December 11, 2016

7.9K

Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer

Shiho Yokoyama-Mashima1, Satomi Yogosawa2, Yumi Kanegae3

  • 1Department of Biochemistry, The Jikei University School of Medicine, Tokyo, Japan; Department of Gastroenterology and Hepatology, The Jikei University School of Medicine, Tokyo, Japan.

Cancer Letters
|March 10, 2019
PubMed

Insights

Dual-specificity tyrosine-regulated kinase 2 (DYRK2) acts as a tumor suppressor in liver cancer. Overexpressing DYRK2 inhibits cancer growth and improves survival, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Liver cancer is aggressive with poor global prognosis, necessitating new therapeutic targets.
  • Dual-specificity tyrosine-regulated kinase 2 (DYRK2) has been identified as a tumor suppressor regulating key cellular processes.
  • The clinical relevance and therapeutic potential of DYRK2 in liver cancer remain underexplored.

Purpose of the Study:

  • To investigate the role of DYRK2 in liver cancer progression and its potential as a therapeutic target.
  • To evaluate the impact of DYRK2 modulation on liver cancer cell behavior in vitro and in vivo.
  • To assess DYRK2 expression as a prognostic marker for liver cancer patients.

Main Methods:

  • DYRK2 knockdown and adenovirus-mediated overexpression in liver cancer cells.
  • In vitro assays for cell proliferation, apoptosis, and tumor growth.
  • In vivo studies using animal models to assess tumor growth inhibition.
  • Analysis of DYRK2 expression levels in patient samples and correlation with overall survival.

Main Results:

  • DYRK2 knockdown accelerated liver cancer cell proliferation and tumor growth.
  • Overexpression of DYRK2 significantly inhibited cancer cell proliferation and tumor growth, inducing apoptosis.
  • Low DYRK2 expression in liver cancer patients correlated with significantly shorter overall survival.
  • DYRK2's regulation of proliferation and apoptosis was confirmed in vitro and in vivo.

Conclusions:

  • DYRK2 functions as a tumor suppressor in liver cancer.
  • DYRK2 expression levels can serve as a predictive marker for liver cancer prognosis.
  • Targeting DYRK2 through gene therapy presents a potential novel therapeutic strategy for liver cancer.
Keywords:
AdenovirusApoptosisDYRK2Liver cancerProliferation

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

17.0K
Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.5K

Related Concept Videos

Real Gases: Effects of Intermolecular Forces and Molecular Volume Deriving Van der Waals Equation04:01

Real Gases: Effects of Intermolecular Forces and Molecular Volume Deriving Van der Waals Equation

Thus far, the ideal gas law, PV = nRT, has been applied to a variety of different types of problems, ranging from reaction stoichiometry and empirical and molecular formula problems to determining the density and molar mass of a gas. However, the behavior of a gas is often non-ideal, meaning that the observed relationships between its pressure, volume, and temperature are not accurately described by the gas laws.
39.0K
Inductive Effects on Chemical Shift: Overview01:27

Inductive Effects on Chemical Shift: Overview

The protons in unsubstituted alkanes are strongly shielded with chemical shifts below 1.8 ppm. Methine, methylene, and methyl protons appear at approximately 1.7, 1.2 and 0.7 ppm, while the proton signal from methane appears at 0.23 ppm. An electronegative substituent, such as chlorine, withdraws the electron density from the protons, increasing their chemical shift. Progressive substitution of the hydrogens in methane by chlorine shifts the proton signals increasingly downfield, to 3.05 ppm in...
2.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.1K